跳至主要内容
临床试验/NL-OMON48363
NL-OMON48363已完成不适用

Diagnostic yield of screening colonoscopy in testicular cancer survivors treated with platinum-based chemotherapy - CATCHER

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 234 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosis of TC before age of 50 years
  • - Treatment of primary TC consisting at least three cycles of platinum-based
  • chemotherapy consisting of cisplatin
  • - At least 8 years after initial treatment
  • - At least 35 years of age and not older than 75 years
  • - Detection and potential treatment of advanced colorectal neoplasia is
  • considered useful

排除标准

  • - A history of a proctocolectomy
  • - Colonoscopy surveillance for other indications (including hereditary CRC
  • syndrome, familial CRC syndrome, inflammatory bowel disease, history of
  • colorectal adenoma or CRC). Result of the prior colonoscopy will be put in the
  • database and used for additional analyses
  • - Having received a colonoscopy in the past three years (however the result of
  • the prior colonoscopy will be put in the database and used for additional
  • - Currently receiving cytotoxic treatment or radiotherapy for malignant disease
  • - Coagulopathy (prothrombin time <50% of control; partial tromboplastin time
  • >50 seconds) or anticoagulants (fenprocoumon, acenocoumarol, platelet
  • aggregation inhibitors or new oral anticoagulants) that cannot be stopped or
  • savely bridged
  • - Comorbidity leading to an impaired physical performance (World health
  • organization (WHO) performance status 3-4) or mental retardation
  • - Limited Dutch language skills
  • - No informed consent

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验